QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 25, no. 2 (2006): 461-468
doi: 10.1377/hlthaff.25.2.461
© 2006 by Project HOPE
 
New Online
 * Pay Cuts For Medicare Docs
 * Access To Care Woes
 * Public Coverage More Efficient
 * Empowering Consumers
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* View responses
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (4)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Keyhani, S.
* Articles by Powe, N.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Keyhani, S.
* Articles by Powe, N.
Related Collections
* Business Of Health
* Legal/Regulatory Issues
* Pharmaceuticals
* Research And Technology
* Health Spending

Health Tracking

TRENDS

Are Development Times For Pharmaceuticals Increasing Or Decreasing?

Salomeh Keyhani, Marie Diener-West and Neil Powe

This study examines trends in drug development times. Longer clinical trial times have been described as one factor leading to higher drug prices. Previous reports on development times have been based on proprietary data. We examined trends in development times for 168 drugs with data collected from publicly available sources. The median clinical trial and regulatory review periods for drugs approved between 1992 and 2002 were 5.1 and 1.2 years, respectively. Clinical trial periods have not increased during this time frame, and regulatory review periods have decreased. Therefore, it is unlikely that longer clinical trial times are contributing to rising prescription drug prices.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
J. M. Hoffman, N. D. Shah, L. C. Vermeulen, G. T. Schumock, P. Grim, R. J. Hunkler, and K. M. Hontz
Projecting future drug expenditures--2007
Am. J. Health Syst. Pharm., February 1, 2007; 64(3): 298 - 314.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

The Real Significance of Drug Development Times
Joseph A. DiMasi, Ph.D.
Health Affairs, 14 Mar 2006 [Full text]
Re: The Real Significance of Drug Development Times
Salomeh Keyhani
Health Affairs, 15 Mar 2006 [Full text]
Re: The Real Significance of Drug Development Times
Donald W. Light
Health Affairs, 21 Mar 2006 [Full text]
A Response To Light From DiMasi
Joseph A. DiMasi
Health Affairs, 24 Mar 2006 [Full text]
High Drug Prices Set by Economic Theory?
Donald W. Light
Health Affairs, 2 Jun 2006 [Full text]
A Response to Light's Rejoinder from DiMasi
Joseph A. DiMasi
Health Affairs, 13 Jun 2006 [Full text]


Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2006 Project HOPE–The People-to-People Organization
Terms and Policies